Global Maple Syrup Urine Disease Treatment Market is projected to Reach USD 11.05 Billion by 2024 to Growing at a CAGR of 11.08% from 2025 to 2035.Maple Syrup Urine Disease Treatment (MSUD) is a rare inherited metabolic disorder caused by a deficiency in the enzyme complex responsible for breaking down branched chain amino acids.